OR WAIT null SECS
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Kenneth W. Sigvardson is a director at The DuPont Pharmaceuticals Company, Experimental Station, PO Box 80353, Wilmington, DE 19880-0353.